Allergy Immunotherapy Market Set for 8.5% CAGR Growth Driven by SCIT and SLIT Innovations

InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Allergy Immunotherapy Market Size, Share & Trends Analysis Report By Treatment Type (SCIT, SLIT), By Allergy Type (Allergic Rhinitis, Asthma), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy), Region, Market Outlook And Industry Analysis 2034"

The global Allergy Immunotherapy market is estimated to reach over USD 4.3 Billion by the year 2034, exhibiting a CAGR of 8.5% during the forecast period.

Get Free Access to Demo Report, Excel Pivot and ToC: https://www.insightaceanalytic.com/request-sample/1924

The projected growth in revenue is strongly correlated with the rising global incidence of allergic diseases, which are exerting increasing pressure on healthcare systems. The escalating prevalence of complex allergic conditions-often associated with elevated morbidity rates-is driving intensified research and development activities, as well as the introduction of innovative treatment solutions. Moreover, the growing number of asthma and respiratory allergy cases is largely attributed to worsening air quality caused by both indoor and outdoor pollution. According to the Asthma and Allergy Foundation of America (AAFA), elevated pollen levels contribute to allergic reactions in more than 25 million individuals in the United States.

In Canada, data from the Canadian Allergy, Asthma, and Immunology Foundation indicates that allergic rhinitis affects approximately 20% to 25% of the population. Traditional symptomatic therapies prove insufficient for nearly half of these patients, thereby encouraging pharmaceutical companies to pursue advanced immunotherapy options. Notably, in 2019, ALK submitted an application to Canadian regulatory authorities for approval of its investigational sublingual immunotherapy (SLIT) tablet targeting tree pollen allergies.

List of Prominent Players in the Allergy Immunotherapy Market:
• ASIT Biotech
• Circassia
• Mylan N.V.
• Adamis Pharmaceuticals Corporation
• Merck KGaA
• Stallergenes Greer plc
• Allergy Therapeutics
• ALK-Abelló A/S
• DESENTUM OY
• HAL Allergy B.V.
• HollisterStier Allergy
• LETIPharma
• DBV Technologies SA

Expert Knowledge, Just a Click Away: https://calendly.com/insightaceanalytic/30min?month=2025-02

Market Dynamics
Drivers:
The global allergy immunotherapy market is poised for substantial growth, primarily driven by the increasing incidence and prevalence of allergic conditions. According to data from the Centers for Disease Control and Prevention (CDC), in 2018, hay fever affected approximately 19.2 million adults and 5.2 million children in the United States. Additionally, rising pollution levels and ongoing environmental changes are further contributing to the expansion of this market. The Asthma and Allergy Foundation of America (AAFA) reports that over 23 million individuals in the U.S. suffer from ragweed pollen allergies, which significantly impair quality of life and often aggravate asthma symptoms in patients with comorbid conditions.

Challenges:
Despite its clinical benefits, allergy immunotherapy faces several barriers to widespread adoption, particularly in the areas of patient adherence and treatment affordability. Limited public awareness and insufficient healthcare funding continue to impede treatment uptake. A 2022 study published by the National Center for Biotechnology Information (NCBI) notes that the time commitment required for subcutaneous immunotherapy (SCIT), along with side effects associated with both SCIT and sublingual immunotherapy (SLIT), often leads to treatment discontinuation. Furthermore, the annual cost of allergy shots in the U.S. ranges from USD 1,600 to USD 4,000 for uninsured individuals, and approximately USD 800 for those with insurance coverage. Notably, SLIT drops have yet to receive FDA approval or insurance reimbursement in the U.S., thereby limiting their accessibility and hindering market penetration.

Regional Trends:
Europe is anticipated to witness the highest compound annual growth rate (CAGR) and retain its leading position in the allergy immunotherapy market over the forecast period. This growth is underpinned by the active presence of major industry players, including ASIT Biotech, Circassia, Mylan N.V., and Merck KGaA. Currently, allergic conditions affect more than 150 million people across Europe. By 2025, it is estimated that over half of the region's population will experience some form of allergy, a trend largely driven by factors such as industrial development, urbanization, climate change, and rising pollution levels.

Unlock Your GTM Strategy: https://www.insightaceanalytic.com/customisation/1924

Recent Developments:
• In July 2022, The good findings regarding the significant advantage of sublingual liquid allergen immunotherapy treatment (AIT) on the beginning and worsening of asthma in patients with allergic rhinitis was released by Stallergenes Greer, a worldwide healthcare firm that specializes in allergen immunotherapy (AIT).

Segmentation of Allergy Immunotherapy Market-
By Treatment Type-
• Subcutaneous Immunotherapy (SCIT)
• Sublingual Immunotherapy (SLIT)
• Tablets
• Drops
By Allergy Type-
• Allergic rhinitis
• Allergic asthma
• Others
By Distribution Channel-
• Hospital Pharmacy
• Retail Pharmacy
• Online Pharmacy
By Region-
North America-
• The US
• Canada
• Mexico
Europe-
• Germany
• The UK
• France
• Italy
• Spain
• Rest of Europe
Asia-Pacific-
• China
• Japan
• India
• South Korea
• Southeast Asia
• Rest of Asia Pacific
Latin America-
• Brazil
• Argentina
• Rest of Latin America
Middle East & Africa-
• GCC Countries
• South Africa
• Rest of the Middle East and Africa

Read Overview Report- https://www.insightaceanalytic.com/report/allergy-immunotherapy-market-/1924

About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.

Contact us:
InsightAce Analytic Pvt. Ltd.
Visit: www.insightaceanalytic.com
Tel : +1 607 400-7072
Asia: +91 79 72967118
info@insightaceanalytic.com

This release was published on openPR.